GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Keyuan Pharmaceutical Co Ltd (SZSE:301281) » Definitions » Construction In Progress

Shandong Keyuan Pharmaceutical Co (SZSE:301281) Construction In Progress : ¥12.8 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shandong Keyuan Pharmaceutical Co Construction In Progress?

Shandong Keyuan Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (¥10.0 Mil) to Dec. 2023 (¥12.2 Mil) and increased from Dec. 2023 (¥12.2 Mil) to Mar. 2024 (¥12.8 Mil).

Shandong Keyuan Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (¥66.2 Mil) to Dec. 2022 (¥20.0 Mil) and declined from Dec. 2022 (¥20.0 Mil) to Dec. 2023 (¥12.2 Mil).


Shandong Keyuan Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Shandong Keyuan Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Keyuan Pharmaceutical Co Construction In Progress Chart

Shandong Keyuan Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial 18.19 22.28 66.23 19.99 12.15

Shandong Keyuan Pharmaceutical Co Quarterly Data
Dec13 Dec14 Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.04 19.38 10.02 12.15 12.77

Shandong Keyuan Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Shandong Keyuan Pharmaceutical Co (SZSE:301281) Business Description

Traded in Other Exchanges
N/A
Address
Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.

Shandong Keyuan Pharmaceutical Co (SZSE:301281) Headlines

No Headlines